This Arizona bioscience firm is going back to the public markets to raise $35M

HTG Molecular Diagnostics Inc. (Nasdaq: HTGM) plans to sell 12.1 million shares of its common stock in an effort to raise $35.1 million. Plans call for using the funds for working capital and general corporate purposes, which could include capital expenditures, research and development, sales and marketing and general and administrative expenses. HTG offers a molecular profiling platform to analyze thousands of genes at a time. T he Tucson-based bioscience company filed its initial public offering…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news